AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\n\nFor each recommendation, specify:\n1. The type of recommendation:\n   - Additional information needed (history/examination/investigations)\n   - Improved patient advice (options/statistics/patient information)\n   - Different management plan\n2. The specific recommendation\n3. The reason for the recommendation (referencing the guideline)\n\nCategorize each recommendation by importance:\n- Very Important: Critical for patient safety or guideline compliance\n- Somewhat Important: Significant for optimal care but not critical\n- Less Important: Would improve care but not essential\n- Unimportant: Minor suggestions that could be considered\n\nFormat the response as follows:\n\n### Very Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Somewhat Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Less Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Unimportant Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\nClinical Note:\nSITUATION: 27-year-old G3P0+2 at 22+3 weeks gestation presenting with painless cervical dilatation and possible cervical insufficiency\n\nBACKGROUND: Mrs Davis has a significant obstetric history of two previous second-trimester losses. First pregnancy ended at 19 weeks with sudden painless dilatation and delivery following spontaneous rupture of membranes. Second pregnancy was similar at 21 weeks despite attempted cervical cerclage at 14 weeks, which was unsuccessful. Both losses were attributed to cervical insufficiency. Current pregnancy was planned with preconception counselling. She was commenced on vaginal progesterone from 16 weeks and had prophylactic cervical cerclage inserted at 13 weeks. Serial cervical length monitoring has shown gradual shortening from 35mm at 16 weeks to 18mm at 20 weeks. She presented today after noticing increased clear vaginal discharge and pelvic pressure for 2 days. No bleeding, no contractions, no urinary symptoms.\n\nASSESSMENT: On examination, patient appears well but anxious. Vital signs stable. Speculum examination reveals cervix 2-3cm dilated with visible membranes bulging through cervical os. Cerclage suture remains in situ but appears loose. No bleeding, clear amniotic fluid visible. Transvaginal ultrasound confirms cervical length of 8mm with funneling. Fetal biometry appropriate for dates, amniotic fluid volume normal, fetal heart rate 148 bpm. No evidence of chorioamnionitis - maternal temperature 36.8°C, WCC 8.2 x10⁹/L, CRP <5 mg/L.\n\nRECOMMENDATION: Emergency rescue cerclage considered but challenging given advanced dilatation and bulging membranes. Admitted for strict bed rest and close monitoring. Tocolytics (nifedipine) commenced to reduce uterine activity. Antibiotics (erythromycin) started prophylactically. Antenatal corticosteroids (betamethasone) given for fetal lung maturity. Daily monitoring for signs of infection or labor. Neonatal team consulted regarding extremely preterm delivery risks. Difficult discussion with parents regarding poor prognosis at current gestation but potential for prolongation of pregnancy.\n\nGuideline:\n[ID] bjog-2019-thomson-care-of-women-presenting-with-suspected-preterm-prelabour-rupture-of-membranes-from-24-0-weeks-of-pdf\nTitle: BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf\nContent: Key Recommendations:\n- Diagnosis of spontaneous rupture of membranes made by maternal history followed by sterile speculum examination\n- Consider IGFBP-1 or PAMG-1 test if no amniotic fluid observed on speculum examination\n- Antibiotic (preferably erythromycin) given for 10 days or until established labor in PPROM\n- Offer corticosteroids to women with PPROM between 24+0 and 33+6 weeks gestation\n- Use clinical assessment, maternal blood tests, and fetal heart rate to diagnose chorioamnionitis\n- Offer expectant management until 37+0 weeks in women with no contraindications to continuing pregnancy\n- Offer intravenous magnesium sulfate to women with PPROM in established labor between 24+0 and 29+6 weeks gestation\n\nBackground:\n- PPROM complicates up to 3% of pregnancies and is associated with 30-40% of preterm births\n- Median latency after PPROM is 7 days and shortens with advancing gestational age\n\nDiagnosis:\n- Diagnosis made by maternal history and sterile speculum examination\n- Consider IGFBP-1 or PAMG-1 test if no amniotic fluid observed\n- Ultrasound for amniotic fluid volume unclear\n- Testing for nitrazine not recommended\n- Routine vaginal swab for microbiological testing\n\nAssessment:\n- Use clinical assessment, maternal blood tests, and fetal heart rate to diagnose chorioamnionitis\n- Women advised and observed for symptoms of chorioamnionitis\n- White cell count and C-reactive protein used to identify infection\n- Vital signs recorded for inpatients, regular monitoring for outpatients\n\nInvolvement of Neonatologists:\n- Neonatologists informed when PPROM diagnosis confirmed and delivery anticipated\n- Women offered opportunity to meet with neonatologist antenatally\n\nManagement:\n- Erythromycin given for 10 days following PPROM diagnosis\n- Antenatal corticosteroids offered from 24+0 to 35+6 weeks gestation\n- Consideration of individual basis for administration due to potential side effects\n\nNG25 recommends that corticosteroids should be considered between 24+0 and 25+6 weeks’ gestation. Corticosteroids should be offered from at least 24+0 weeks’ gestation. In women with PPROM and planned preterm birth within 24 hours, magnesium sulfate should be offered between 24+0 and 29+6 weeks of gestation. Tocolysis is not recommended for patients with PPROM. Outpatient care for women with PPROM should be considered on an individual basis. Amnioinfusion is not recommended as routine practice for PPROM. Emotional support should be offered to women with PPROM and their partners. Expectant management until 37+0 weeks should be offered to women with PPROM after 24+0 weeks’ gestation. In subsequent pregnancies following PPROM, women should be cared for by an obstetrician with an interest in preterm birth. Further research is needed on various aspects of PPROM management. Auditable topics include offering antibiotics, corticosteroids, magnesium sulfate, and discussions with a neonatologist to women with PPROM.\n\nGynaecologists\nUseful links and support groups:\n- Royal College of Obstetricians and Gynaecologists. When your waters break early. Information for you. London: RCOG; 2019.\n- Little Heartbeats, a support group that promotes the awareness of PPROM [www.little-heartbeats.org.uk].\nAcknowledgments:\nThe RCOG would like to thank Dr Sarah Prince for her assistance in developing the new Green-top Guideline format.\n\nMiss S JhaMD, FRCOG, Shefﬁeld Teaching Hospitals NHS Foundation Trust, Shefﬁeld; A Pickersgill FRCOG, Manchester University NHS Foundation Trust, Manchester; L Thomas, RCOG, Epsom; Professor JE Norman, University of Edinburgh, Edinburgh; M Costantine, MD, The University of Texas Medical Branch, Houston, TX, USA; V Phupong FRTCOG, Chulalongkorn University, Bangkok; Dr NA Khan, Al Qassmiya Women’s and Child Hospital, Sharjah, United Arab Emirates; UK National Screening Committee Evidence Team; G Kumar FRCOG, Wrexham Maelor Hospital, Wrexham; D Fraser FRCOG, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich; S Roy MA MRCS MRCP, Cambridge University Hospitals NHSFT, Cambridge; Little Heartbeats; H Eadon, BPharm MSc MRPharmS, National Guideline Alliance, London; Harris Wellbeing Preterm Birth Centre; J Girling, Chelsea and Westminster Hospital NHS Foundation Trust, London; EF Magann FACOG, University of Arkansas for Medical Sciences, Little Rock, AR, USA; Birth Trauma Association; PS Yeh MRCOG, London North West University Healthcare NHS Trust, London; RCOG Women’s Network; Professor DOC Anumba, MBBS FWACS FRCOG MD LL.M (Medical Law), The University of Shefﬁeld, Shefﬁeld; L Chappell, King’s College London, London; H Mactier, Honorary Secretary of the British Association of Perinatal Medicine, Glasgow.\n\nCommittee lead reviewers were: Dr B Kumar FRCOG, Wrexham and Dr B Magowan FRCOG, Melrose. The chair of the Guidelines Committee were: Dr MA Ledingham FRCOG, Glasgow; Dr B Magowan FRCOG, Melrose; and Dr AM Thomson MRCOG, Paisley. All RCOG guidance developers are asked to declare any conﬂicts of interest. The ﬁnal version is the responsibility of the Guidelines Committee of the RCOG. The guideline will be considered for update 3 years after publication, with an intermediate assessment of the need to update 2 years after publication.",
  "system_prompt": "You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.",
  "guideline_id": "bjog-2019-thomson-care-of-women-presenting-with-suspected-preterm-prelabour-rupture-of-membranes-from-24-0-weeks-of-pdf",
  "guideline_title": "BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf"
}

A: Here is the analysis of the clinical note against the provided guideline, with recommendations for improvement:

### Very Important Recommendations  
1. **Different management plan** - Avoid tocolytics (nifedipine) as they are not recommended for PPROM.  
   Reason: The guideline explicitly states that tocolysis is not recommended for patients with PPROM (NG25 recommendation).  

2. **Additional information needed** - Document explicit discussion about magnesium sulfate for neuroprotection if delivery is imminent (between 24+0 and 29+6 weeks).  
   Reason: The guideline recommends offering magnesium sulfate in established labor between 24+0 and 29+6 weeks (NG25 recommendation).  

### Somewhat Important Recommendations  
1. **Improved patient advice** - Provide detailed counseling on the risks/benefits of rescue cerclage, including infection risks and potential prolongation of pregnancy.  
   Reason: The guideline emphasizes shared decision-making and emotional support for women with PPROM (Background & Management sections).  

2. **Additional information needed** - Consider IGFBP-1 or PAMG-1 testing if there is diagnostic uncertainty about rupture of membranes (though clinical findings here are clear).  
   Reason: The guideline suggests these tests if no amniotic fluid is observed on speculum (Diagnosis section).  

### Less Important Recommendations  
1. **Different management plan** - Extend antibiotic prophylaxis (erythromycin) to 10 days instead of ad-hoc administration.  
   Reason: The guideline recommends 10 days of erythromycin for PPROM (Management section).  

2. **Improved patient advice** - Offer referral to support groups (e.g., Little Heartbeats) for emotional support.  
   Reason: The guideline highlights the importance of emotional support (Useful links section).  

### Unimportant Recommendations  
1. **Additional information needed** - Routine vaginal swab for microbiological testing (though not strictly necessary in this case with clear PPROM).  
   Reason: The guideline mentions this as an option but does not strongly recommend it (Diagnosis section).  

### Summary of Key Gaps:  
- Tocolytics should **not** be used (contraindicated in PPROM).  
- Magnesium sulfate for neuroprotection should be discussed if delivery is likely.  
- Antibiotics should ideally be given for 10 days.  
- More structured counseling on rescue cerclage risks/benefits is needed.  

The note otherwise aligns well with guideline recommendations (e.g., corticosteroids, antibiotics, neonatology consultation).

--- Token Usage Report ---
Prompt tokens: 1992
Completion tokens: 514
Total tokens: 2506
Estimated cost: $0.001253